MATPharm

Short Description of Study

The MATPharm Study team at Rhode Island Hospital seeks participants for a 3-month study to try out a new approach for providing medication care for people with opioid use disorder. The study compares usual care to a new care approach at a specialty community pharmacy.

Keyword Description of Study

OUD and Pharmacy | OUD Care Innovations

Eligibility Requirements

Over 18 -Prescribed buprenorphine/Suboxone or naltrexone/Vivitrol or are interested in starting buprenorphine/Suboxone -live in Rhode Island

Study Contact Info

Full Name

Rachel Serafinski

Email

Email hidden; Javascript is required.

Study Website

lifespan-matpharm.org

ClinicalTrials.gov URL

clinicaltrials.gov

Lifespan Clinical Trials URL

xperttrial.com

Compensation

Yes

Time Involved

2 visits with study team, 3 months

Study Requirements

-receive medication treatment with buprenorphine/Suboxone or naltrexone/Vivitrol, either from the pharmacy or from their usual care provider
-meet in person or remotely with study staff at start and end of study (2 visits)
-call/text mid-point check-in

Participating Organization

NIH/NIDA

Upload QR Code

Picture1.png